The Role of Dexmedetomidine in Paroxysmal Sympathetic Hyperactivity: A Systematic Review.

Published in: The Annals of pharmacotherapy (2023)

The use of dexmedetomidine appears to be both efficacious and safe for the treatment and prevention of PSH in patients experiencing a TBI. Additional research is needed to elucidate dosing strategies, titration parameters, and duration of therapy.

Keyphrases

end stage renal disease
ejection fraction
traumatic brain injury
newly diagnosed
chronic kidney disease
atrial fibrillation
peritoneal dialysis
stem cells
bone marrow